InvestorsHub Logo
Followers 9
Posts 2033
Boards Moderated 0
Alias Born 08/26/2010

Re: Protector post# 177129

Tuesday, 05/20/2014 12:10:47 PM

Tuesday, May 20, 2014 12:10:47 PM

Post# of 346112
5) Is still 2014 (results as projected by PPHM - not MLV)

Once again misleading information. Data was supposed to be presented first quarter 2014.

A Phase I/II IST evaluating bavituximab in combination with sorafenib in up to 48 patients with advanced hepatocellular carcinoma (liver cancer). Interim data has been accepted for oral presentation at an upcoming scientific conference in the first quarter of 2014.

Per IR, the Liver IST Interim Data Update will occur in MARCH (NOT MAY, EBS), as promised In the 12-10-13 10K press release (Q1'14). It will occur in this March 13th presentation
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News